Position in JSPR
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$933,981
-$1,017,144 QoQ
Shares Held
1,066,189
0.0% QoQ
Ownership
3.81%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JSPR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Carlyle Group Inc. holds $52,484,251 across 8 Biotechnology names. JSPR ranks #6 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHAT |
Phathom Pharmaceuticals, Inc.
|
3,496,808 | $38,849,536 | |
| 2 | QTTB |
Q32 Bio Inc.
|
1,102,741 | $7,079,597 | |
| 3 | SPRB |
Spruce Biosciences, Inc.
|
38,620 | $2,523,817 | |
| 4 | ACET |
Adicet Bio, Inc.
|
184,295 | $1,255,048 | |
| 5 | OKUR |
OnKure Therapeutics, Inc.
|
269,895 | $1,117,365 | |
| 6 | JSPR |
Jasper Therapeutics, Inc.
This page
|
1,066,189 | $933,981 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
9,620 | $485,232 | |
| 8 | XCUR |
Exicure, Inc.
|
56,328 | $239,675 |
All Filings in JSPR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $933,981 | 1,066,189 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,951,125 | 1,066,189 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,537,529 | 1,066,189 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $5,917,348 | 1,066,189 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $4,584,612 | 1,066,189 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $22,795,120 | 1,066,189 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $20,055,015 | 1,066,189 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $24,202,490 | 1,066,189 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $31,303,309 | 1,066,189 | Shares | Defined | 2024-05-03 | |
| No filing history on record for this holder in this stock. | ||||||